Total Payments
$633.11
2024 Payments
$121.83
Companies
9
Transactions
25
Payment Breakdown by Category
Food & Beverage$633.11 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $633.11 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $183.19 | 5 | $0 (2024) |
| Alkermes, Inc. | $165.98 | 3 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $100.74 | 7 | $0 (2022) |
| AbbVie Inc. | $57.79 | 3 | $0 (2021) |
| Braeburn Inc. | $47.33 | 2 | $0 (2023) |
| ITI, Inc. | $34.57 | 2 | $0 (2022) |
| Ironshore Pharmaceuticals Inc. | $15.24 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $14.37 | 1 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $13.90 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.83 | 1 | Otsuka America Pharmaceutical, Inc. ($121.83) |
| 2023 | $74.46 | 3 | Braeburn Inc. ($47.33) |
| 2022 | $185.13 | 5 | Alkermes, Inc. ($138.85) |
| 2021 | $251.69 | 16 | Supernus Pharmaceuticals, Inc. ($72.38) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Opioid Use Disorder | ||||||
| 10/11/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Opioid Use Disorder | ||||||
| 05/25/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: CNS | ||||||
| 12/16/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: CNS | ||||||
| 09/27/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $109.18 | General |
| Category: CNS | ||||||
| 08/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: PSYCHOLOGY | ||||||
| 02/24/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: PSYCHOLOGY | ||||||
| 12/01/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: PSYCHOLOGY | ||||||
| 11/10/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: PSYCHOLOGY | ||||||
| 10/22/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: PSYCHOLOGY | ||||||
| 09/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.68 | General |
| Category: PSYCHOLOGY | ||||||
| 06/15/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: PSYCHIATRY | ||||||
| 06/15/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: CNS | ||||||
| 05/25/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/25/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.33 | General |
| Category: PSYCHOLOGY | ||||||
| 05/06/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PSYCHIATRY | ||||||
| 03/30/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 01/08/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: PSYCHIATRY | ||||||
About Michael Yoakum, CNP
Michael Yoakum, CNP is a Psychiatric/Mental Health healthcare provider based in Fairborn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2018. The National Provider Identifier (NPI) number assigned to this provider is 1205328739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Yoakum, CNP has received a total of $633.11 in payments from pharmaceutical and medical device companies, with $121.83 received in 2024. These payments were reported across 25 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($633.11).
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Fairborn, OH
- Active Since 05/31/2018
- Last Updated 05/31/2018
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1205328739
Products in Payments
- REXULTI (Drug) $165.42
- VIVITROL (Drug) $138.85
- QELBREE (Drug) $100.74
- VRAYLAR (Drug) $57.79
- BRIXADI (Drug) $47.33
- CAPLYTA (Drug) $34.57
- Vivitrol (Drug) $27.13
- ABILIFY MAINTENA (Drug) $17.77
- JORNAY PM (Drug) $15.24
- LATUDA (Drug) $14.37
- NUEDEXTA (Drug) $13.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Fairborn
Hilda Ngoh, Pmhmp-Bc, PMHMP-BC
Psychiatric/Mental Health — Payments: $4,617
Psychiatric/Mental Health $4,617
Belinda Niece, Aprn-Cnp, APRN-CNP
Psychiatric/Mental Health — Payments: $251.69
Psychiatric/Mental Health $251.69
Sheila Dunn, Pmhnp-Bc, Rn, Msn, PMHNP-BC, RN, MSN
Psychiatric/Mental Health — Payments: $171.78
Psychiatric/Mental Health $171.78
Melissa Root, Aprn, APRN
Psychiatric/Mental Health — Payments: $13.17
Psychiatric/Mental Health $13.17
Amy Jones-Hummel, Rn, RN
Psychiatric/Mental Health
Psychiatric/Mental Health